Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the development of innovative cancer treatments. Through science and technology, the company strives to develop and commercialize products that address unmet medical needs, improve survival and have a favorable safety profile. Additionally, Dendreon develops therapeutic vaccines that stimulate the body's immune system to help fight cancer by targeting dendritic cells, which initiate an immune response to disease-causing antigens. The company also develops vaccines to treat breast, colorectal, lung, ovarian and uterine cancers along with monoclonal antibodies to fight blood cancers, such as non-Hodgkin's and B-cell lymphomas. Its partners include Japan's Kirin Brewery and Genentech. Dendreon Corporation is located in Seattle.

Website: dendreon.com

Phone: (206) 256-4545

Cross Streets: Near the intersection of Eastlake Ave E and E Nelson Pl